A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.

NCT07134842 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Gliosarcoma, Adult
Glioblastoma - Category

Interventions

BIOLOGICAL: Ipilimumab (3 mg/kg)

Sponsor

University College, London